March 9, 2018Open Access

Low Estrogen Receptor (ER)–Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy

Key Points

Key points are not available for this paper at this time.

Abstract

Low ER+ breast cancers are biologically similar to ER- tumors. Semiquantitative ER H-score is an important determinant of response to neoadjuvant chemotherapy.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Alessandra Landmann

Daniel J. Farrugia

Li Zhu

Journals

American Journal of Clinical Pathology

Actions

Institutions

University of Pittsburgh

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Low Estrogen Receptor (ER)–Positive Breast Cancer and Neoadjuvant Systemic Chemotherapy

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study